Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of TPN171H on Semen Function in Healthy Males
NCT05585931Phase 1Completed
- Sponsor
- Vigonvita Life Sciences
- Start
- Nov 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TPN171H in erectile dysfunction (ED) (2 arms), sponsored by Vigonvita Life Sciences. Primary endpoints: Effect on semen function and Seminal plasma exposure. Started Nov 2022; status: completed.
02
Drugs
TPN171H
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05585931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585931.